BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 1229130)

  • 1. [Long-term management of various hyperlipidemias using clofibrate].
    Studlar M; Pichler O; Kindler K
    Wien Med Wochenschr; 1975 Dec; 125(50-52):746-51. PubMed ID: 1229130
    [No Abstract]   [Full Text] [Related]  

  • 2. [Long-term effect of alufibrate in various types of hyperlipidaemia (author's transl)].
    Stähelin HB; Hartmann G
    Dtsch Med Wochenschr; 1974 Jun; 99(26):1392-4 passim. PubMed ID: 4601124
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacokinetics of clofibrate in uremic patients treated with dialysis. Effects of dietetic and drug therapy on triglycerides in the blood].
    Garini G; Vaona GL; Arisi L; Bignardi L; David S; Gaudiano V; Rossi E; Savazzi GM; Cambi V; Migone L
    Minerva Nefrol; 1979; 26(1):55-60. PubMed ID: 471323
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hyperlipiemia and its therapy by clofibrate].
    Nakano M; Nakamura Y
    Iryo; 1969 Dec; 23(12):1473-8. PubMed ID: 5381198
    [No Abstract]   [Full Text] [Related]  

  • 5. Gemfibrozil and clofibrate in the treatment of hyperlipidaemias. A comparative trial.
    Eisalo A; Manninen V
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):44-6. PubMed ID: 798196
    [No Abstract]   [Full Text] [Related]  

  • 6. [Combination of clofibrate and phenformin in the treatment of endogenous hypertriglyceridaemia (author's transl)].
    Vogelberg KH
    Dtsch Med Wochenschr; 1976 Dec; 101(51):1868-71. PubMed ID: 1001205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of a combined treatment using clofibrate and persantin persantinat on increased serum lipid levels].
    Hammerl H; Nebosis G; Pichler O; Studlar M
    Med Welt; 1973 Mar; 24(12):468-70. PubMed ID: 4700881
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypolipaemic drugs and coronary heart disease.
    Howard AN
    J Clin Pathol Suppl (R Coll Pathol); 1975; 9():106-14. PubMed ID: 783209
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of clofibrate on glucide tolerance in patients with ischemic heart disease and hyperlipoproteinemia].
    Bornemisza P; Csögör I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1978; 30(6):543-6. PubMed ID: 34860
    [No Abstract]   [Full Text] [Related]  

  • 10. [Problems of long-term treatment of hyperlipoproteinemia with clofibrinic acid].
    Hanefeld M; Schulze J; Fritz T; Kemmer C
    Z Gesamte Inn Med; 1973 May; 28(10):Suppl 10:160 c. PubMed ID: 4200340
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results of long-term treatment of hyperlipemias].
    Reuter W
    Z Gesamte Inn Med; 1973 May; 28(10):Suppl 10:156-9. PubMed ID: 4200339
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum cholesterol and triglycerides.
    Myant NB
    Practitioner; 1973 Aug; 211(262):188-92. PubMed ID: 4728419
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term treatment of hyperlipidemic patients with clofibrate.
    Berkowitz D
    JAMA; 1971 Nov; 218(7):1002-5. PubMed ID: 5000568
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of long term treatment with hydrophilic colloid on serum lipids.
    Danielsson A; Ek B; Nyhlin H; Steen L
    Acta Hepatogastroenterol (Stuttg); 1979 Apr; 26(2):148-53. PubMed ID: 111460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A physician's guide to hyperlipidemia.
    Fredrickson DS
    Mod Concepts Cardiovasc Dis; 1972 Jul; 41(7):31-6. PubMed ID: 4343098
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum lipids in an ambulary diabetic clientele. Effect of therapy with Atromidin (clofibrate).
    Bergqvist N
    Acta Med Scand; 1970 Mar; 187(3):213-8. PubMed ID: 5444978
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hypolipemic property and myotoxic action of clofibrate in a case of nephrotic syndrome].
    Fabre J; Denizot M; Wildi E; Micheli H; Berthoud S
    Schweiz Rundsch Med Prax; 1973 Jun; 62(23):732-7. PubMed ID: 4705828
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of symfibrate in the treatment of hyperlipemias. Preliminary data].
    Giuliani A; Trezzini C; Urbinati G; Conti R
    Clin Ter; 1979 Mar; 88(5):481-9. PubMed ID: 466970
    [No Abstract]   [Full Text] [Related]  

  • 19. Factorial study of the efficacy of cholestyramine, L-tryptophan and clofibrate in human nephrotic hyperlipidaemia.
    Schapel GJ; Edwards KD; Neale FC
    Prog Biochem Pharmacol; 1974; 9():82-98. PubMed ID: 4438384
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of hyperlipidaemia. A comparison of the efficacy of clofibrate and beta-pyridylcarbinol (author's transl)].
    Wolfram G; Keller C; Kilani S; Zöllner N
    Dtsch Med Wochenschr; 1976 Jan; 101(3):76-81. PubMed ID: 1245160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.